To make healthcare diagnostics accessible, affordable, accountable and unambiguous to all
Optimal utilization of technological advances in all the scientific disciplines to enhance the efficiency of medical care.
Welcome to Cephalobits
Cephalobits leads the way in modern healthcare innovation, completely transforming the field of medical diagnostics with our groundbreaking product, Biosniff (Patent Pending). Drawing inspiration from the clinical use of human breath as a diagnostic tool, Cephalobits has leveraged advanced technology from microbiology, biophotonics, and Artificial Intelligence fields to develop a revolutionary tool for diagnosing diseases and monitoring health using exhaled human breath.
LATEST NEWS
What does AI mean for neurological disorders? Dr. Rajarathinam Ayyanar MD, DM, Co-founder and Chief Science Officer of Cephalobits, presented at the Artificial Intelligence and Innovation in Healthcare Summit in Dubai.
Cepholobits Biosniff Diagnostic Solution is making waves. Conference attendees show excitement for the possibilites Biosniff will introduce to world health. The accessibility aspect of Biosniff is especially interesting.
Cepholobits’ leadership sat for an interview to discuss the Biosniff Diagnostic Solution And its impact on global accessibility to health diagnostics. Biosniff will make health diagnostics accessible to everyone irrelevant of their proximity to advanced medical Facilities.
Cepholobits presented the Biosniff Diagnostic Solution in Kuwait attended by Government Leaders, Investors, and industry experts
Projects
Language as a tool to diagnose
The most complex and the highly evolved function of the brain is language.
Non-invasive coronary artery patency evaluation
There are many non-invasive methods to detect the failing heart like electrophysiology,
Prediction of stroke
Brain stroke is the third major killer of the humans and those who survived might be left with significant morbidity.